Northern Trust’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-944,870
| Closed | -$2.93M | – | 4880 |
|
|
2021
Q4 | $2.93M | Sell |
944,870
-86,522
| -8% | -$291K | ﹤0.01% | 3020 |
|
|
2021
Q3 | $3.72M | Buy |
1,031,392
+21,803
| +2% | +$82.2K | ﹤0.01% | 2929 |
|
|
2021
Q2 | $3.61M | Sell |
1,009,589
-22,627
| -2% | -$79.8K | ﹤0.01% | 3036 |
|
|
2021
Q1 | $4.04M | Sell |
1,032,216
-34,923
| -3% | -$144K | ﹤0.01% | 2877 |
|
|
2020
Q4 | $4.48M | Sell |
1,067,139
-25,627
| -2% | -$98.8K | ﹤0.01% | 2742 |
|
|
2020
Q3 | $4.08M | Sell |
1,092,766
-20,075
| -2% | -$85.4K | ﹤0.01% | 2656 |
|
|
2020
Q2 | $4.85M | Buy |
1,112,841
+96,977
| +10% | +$436K | ﹤0.01% | 2547 |
|
|
2020
Q1 | $3.85M | Buy |
1,015,864
+17,465
| +2% | +$85.8K | ﹤0.01% | 2458 |
|
|
2019
Q4 | $6.31M | Sell |
998,399
-167,173
| -14% | -$983K | ﹤0.01% | 2456 |
|
|
2019
Q3 | $4.91M | Buy |
1,165,572
+906,824
| +350% | +$3.87M | ﹤0.01% | 2566 |
|
|
2019
Q2 | $1.2M | Buy |
258,748
+73,637
| +40% | +$343K | ﹤0.01% | 3299 |
|
|
2019
Q1 | $982K | Sell |
185,111
-4,258
| -2% | -$19.4K | ﹤0.01% | 3363 |
|
|
2018
Q4 | $701K | Sell |
189,369
-1,765
| -0.9% | -$6.2K | ﹤0.01% | 3466 |
|
|
2018
Q3 | $535K | Buy |
191,134
+118
| +0.1% | +$331 | ﹤0.01% | 3616 |
|
|
2018
Q2 | $563K | Buy |
191,016
+31,749
| +20% | +$75.3K | ﹤0.01% | 3575 |
|
|
2018
Q1 | $359K | Buy |
159,267
+3,613
| +2% | +$8.46K | ﹤0.01% | 3653 |
|
|
2017
Q4 | $459K | Sell |
155,654
-972
| -0.6% | -$2.69K | ﹤0.01% | 3578 |
|
|
2017
Q3 | $462K | Buy |
156,626
+16,176
| +12% | +$49.3K | ﹤0.01% | 3583 |
|
|
2017
Q2 | $394K | Buy |
140,450
+1,203
| +0.9% | +$2.54K | ﹤0.01% | 3627 |
|
|
2017
Q1 | $265K | Buy |
139,247
+9,189
| +7% | +$17.7K | ﹤0.01% | 3707 |
|
|
2016
Q4 | $228K | Buy |
130,058
+7,963
| +7% | +$16.3K | ﹤0.01% | 3722 |
|
|
2016
Q3 | $330K | Sell |
122,095
-11,056
| -8% | -$28.1K | ﹤0.01% | 3604 |
|
|
2016
Q2 | $314K | Sell |
133,151
-429,643
| -76% | -$1.19M | ﹤0.01% | 3612 |
|
|
2016
Q1 | $1.82M | Buy |
562,794
+3,028
| +0.5% | +$11.2K | ﹤0.01% | 3042 |
|
|
2015
Q4 | $2.68M | Buy |
559,766
+10,575
| +2% | +$60K | ﹤0.01% | 2873 |
|
|
2015
Q3 | $3.05M | Buy |
549,191
+66,465
| +14% | +$491K | ﹤0.01% | 2783 |
|
|
2015
Q2 | $3.84M | Buy |
482,726
+6,664
| +1% | +$57.3K | ﹤0.01% | 2685 |
|
|
2015
Q1 | $5M | Buy |
476,062
+6,418
| +1% | +$87.7K | ﹤0.01% | 2505 |
|
|
2014
Q4 | $5.64M | Sell |
469,644
-3,859
| -0.8% | -$58.6K | ﹤0.01% | 2424 |
|
|
2014
Q3 | $8.09M | Buy |
473,503
+55,739
| +13% | +$809K | ﹤0.01% | 2182 |
|
|
2014
Q2 | $5.04M | Buy |
417,764
+2,536
| +0.6% | +$24K | ﹤0.01% | 2513 |
|
|
2014
Q1 | $3.5M | Sell |
415,228
-16,415
| -4% | -$132K | ﹤0.01% | 2789 |
|
|
2013
Q4 | $2.54M | Buy |
431,643
+4,722
| +1% | +$24.3K | ﹤0.01% | 3015 |
|
|
2013
Q3 | $2.32M | Buy |
426,921
+105,122
| +33% | +$505K | ﹤0.01% | 3009 |
|
|
2013
Q2 | $1.31M | Buy |
+321,799
| New | +$1.51M | ﹤0.01% | 3194 |
|
Other funds holding BDSI
Northern Trust's BDSI Position: Q1 2022 in Review
Northern Trust sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 944,870 shares — an estimated $2.93M sold.
Northern Trust first reported a position in BDSI in Q2 2013 and held it in 35 quarters. The position peaked at $8.09M in Q3 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Northern Trust reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Northern Trust sold 944,870 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $2.93M.
- Northern Trust first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 35 quarters.
- Northern Trust's BioDelivery Sciences International, Inc. position peaked at $8.09M in Q3 2014.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Northern Trust's 13F filing for Q1 2022, filed 13 May 2022.